Lance Kurata
CIK: 0001820961
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARCT
Arcturus Therapeutics Holdings Inc.
Officer
Discretionary Trading P&L
Holdings
About Kurata Lance
Kurata Lance (SEC CIK 0001820961) files insider reports with the SEC as Chief Legal Officer of Arcturus Therapeutics Holdings Inc. (ARCT).
Signal8 holds 2 ownership filings by Kurata Lance, all Form 4s, filed between Dec 18, 2024 and Dec 19, 2025. Those filings report 2 transactions, from Dec 16, 2024 to Dec 17, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kurata Lance's filings is in SAN DIEGO, CA.
Recent filings by Kurata Lance
Other insiders filing for Arcturus Therapeutics Holdings Inc. (ARCT)
- HOLMES EDWARD W, Director
- FARRELL PETER C, Director
- BARLOW JAMES F, Director
- Markels John, Director
- Slaoui Moncef, Director
- Marquet Magda, Director